DETAILED ACTION
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of pre-AIA 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
(b) the invention was patented or described in a printed publication in this or a foreign country or in public use or on sale in this country, more than one year prior to the date of application for patent in the United States.
Claims 1-13 are rejected under pre-AIA 35 U.S.C. 102(b) as being anticipated by Zdeblick et al. (US 5782919).
Regarding claims 1, 7 and 8, Zdeblick discloses a system for delivery of a spinal implant to a spinal joint space including: an elongated shaft portion or tubular body 50 having a proximal portion defining a proximal end and a distal portion defining a distal end, the elongated body defining a lumen; an internal actuator 51 extending through the lumen and an implant engagement portion extending from and integral with the distal portion of the elongated body including opposing first and second prongs or engagement portions 54 that extend in parallel in a spaced apart configuration (Fig. 9) wherein prongs 54 are configured to receive or capable of receiving at least a portion of a monolithic spinal implant or facet joint implant 30; and a device or handle at the proximal part of actuator 51 that enables rotation of the actuator 51 and facilitates implant placement (Figs. 9-10, col. 5, lines 13-67, cols. 6-10 and col. 11, lines 1-33).
Regarding claims 2 and 9, implant 30 is a spinal implant or facet joint implant because it can be placed in a suitably facet joint of a patient (see for e.g. use of a threaded implant in a facet joint, Fisher et al. (US 20080234758)). Specific structure is not recited in the claim to distinguish over the Zdeblick implant.
Regarding claims 3 and 10, implant 30 has a proximal end face, a distal end face, a first surface and a second surface (defined by truncated side walls 22) and teeth defined by peaks of threads 18 (Figs. 2, 8 and 10).
Regarding claims 4 and 11, the recitation “spinal joint space is a cervical facet joint” is intended use and the Zdeblick et al. implant is fully capable of being used in a cervical facet joint, depending on the anatomical characteristics of a patient.
Regarding method claims 5, 6, 12 and 13, the Zdeblick et al. implant is used to insert an implant into an intervertebral space or spinal joint to distract and restore the normal angular relationship of the vertebrae adjacent the intervertebral space (see abstract).
Claims 1-2, 4-9 and 11-13 are rejected under pre-AIA 35 U.S.C. 102(b) as being anticipated by Bagby (US 4501269).
Regarding claims 1, 7 and 8, Bagby discloses a system for delivery of a spinal implant to a spinal joint space including: an elongated shaft portion or tubular body 20 having a proximal portion and a distal portion, the shaft defining a lumen; an internal actuator 19 extending through the lumen, actuator 19 having proximal and distal parts; and an implant engagement portion 28 extending from and integral the distal end of tubular body 20 including prongs 21 that extend in parallel (Fig. 6) wherein prongs 21 are configured to receive or capable of receiving at least a portion of a monolithic spinal implant or facet joint implant 10; and a handle 18 coupled with the proximal part of the internal actuator 19 (Figs. 1-6, col. 3, lines 28-68, col. 4 and col. 5, lines 1-39).
Regarding claims 2 and 9, basket 10 is a spinal implant or facet joint implant. No specific structure is recited in the claim to distinguish over the Bagby implant.
Regarding claims 4 and 11, the recitation “spinal joint space is a cervical facet joint” is intended use and the Bagby implant is fully capable of being used in a cervical facet joint, depending on the anatomical characteristics of a patient (see for e.g. Fig. 7 of Carl et al. (US 20060036323)).
Regarding method claims 5-6, 12 and 13, the Bagby implant is used to insert an implant into an intervertebral space or spinal joint to distract and restore the normal angular relationship of the vertebrae adjacent the intervertebral space (see abstract).
Claim Rejections - 35 USC § 103
The following is a quotation of pre-AIA 35 U.S.C. 103(a) which forms the basis for all obviousness rejections set forth in this Office action:
(a) A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Patentability shall not be negatived by the manner in which the invention was made.
Claims 14-17 are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Zdeblick et al. (US 5782919) in view of Lipovsek et al. (US 4736738).
Zdeblick et al. disclose all elements of the claimed invention except for providing the various instruments in a kit configuration. Regarding claim 15, Zdeblick et al. disclose the use of an outer sleeve 76 that operates as a working channel for a laparoscopic approach (col. 9, lines 45-65). See previous discussion for claims 1-13.
It is well known to provide instruments used for spinal surgery such as spinal fusion in a kit for ease of access to the various instruments that are specifically adapted for use in the surgical procedure, as evidenced by Lipovsek et al. (col. 2, lines 26-34).
It would have been obvious to one of ordinary skill in the art to have provided the various instrumentation of Zdeblick et al. in a kit configuration, as taught by Lipovsek et al., for ease of access to instruments that are specifically adapted for use in a specific procedure.
Claims 14 and 16 are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Bagby (US 4501269) in view of in view of Lipovsek et al. (US 4736738).
Bagby discloses all elements of the claimed invention except for providing the various instruments in a kit configuration. See previous discussion for claims 7-9 and 11-13.
It is well known to provide instruments used for spinal surgery such as spinal fusion in a kit for ease of access to the various instruments that are specifically adapted for use in the surgical procedure, as evidenced by Lipovsek et al. (col. 2, lines 26-34).
It would have been obvious to one of ordinary skill in the art to have provided the various instrumentation of Bagby in a kit configuration, as taught by Lipovsek et al., for ease of access to instruments that are specifically adapted for use in a specific procedure.
Claim 15 is rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Bagby (US 4501269) and Zdeblick et al. (US 5782919) further in view of Lipovsek et al. (US 4736738).
Bagby discloses all elements of the claimed invention except for a guide tube.
Regarding claim 15, Zdeblick et al. disclose the use of an outer sleeve 76 that operates as a working channel for a laparoscopic approach (col. 9, lines 45-65).
It would have been obvious to have utilized the guide tube of Zdeblick et al. to introduce the Bagby implant to facilitate insertion in a minimally invasive manner.
It is well known to provide instruments used for spinal surgery such as spinal fusion in a kit for ease of access to the various instruments that are specifically adapted for use in the surgical procedure, as evidenced by Lipovsek et al. (col. 2, lines 26-34).
Therefore, it would have been obvious to one of ordinary skill in the art to have provided the various instrumentation of the combination of Bagby and Zdeblick et al. in a kit configuration, as taught by Lipovsek et al., for ease of access to instruments that are specifically adapted for use in a specific procedure.
Response to Arguments
Applicant's arguments have been fully considered by the Examiner.
Applicant’s arguments with respect to the rejections under 35 USC 102(b) over Zdeblick et al. are not found to be persuasive because they are not directed to claim limitations. Applicant’s disclosure appears to show a parallel configuration of the implant engagement arms 148 (Figs. 8 and 10). However, Applicant’s disclosure does not state that the parallel configuration is maintained during insertion nor does Applicant’s disclosure require the arms 148 to be rigid.
Applicant’s arguments with respect to the rejections under 35 USC 102(b) over Bagby are not persuasive because they are not directed to claim limitations. Applicant’s disclosure appears to show a parallel configuration of the implant engagement arms 148 (Figs. 8 and 10). However, Applicant’s disclosure does not state that the parallel configuration is maintained during insertion nor does Applicant’s disclosure require the arms 148 to be rigid.
Conclusion
THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Anu Ramana whose telephone number is (571)272-4718. The examiner can normally be reached 8:00 am-5:00 pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Truong can be reached at (571)272-4705. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
February 23, 2026
/Anu Ramana/Primary Examiner, Art Unit 3775
Prosecution Insights